Skip to content

Evaluation and Control of WAG in PACU Within Patient and Caregiver Breathing Zone

Evaluation and Control of Waste Anesthetic Gas (WAG) in the Post Anesthesia Care Unit (PACU) Within Patient and Caregiver Breathing Zone

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02428413
Enrollment
125
Registered
2015-04-28
Start date
2015-04-30
Completion date
2015-12-31
Last updated
2016-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Waste Anesthetic Gas (WAG) Emanating From Patients Post-operative Recovery

Keywords

Waste Anesthetic Gas (WAG)

Brief summary

The purpose of this study is to evaluate anesthetic gas in the PACU within patient and caregiver breathing zones.

Detailed description

The purpose of this single-center, multi-arm, randomized controlled study is to evaluate use of the ISO-Gard mask in patients immediately following a surgical procedure in which inhaled anesthetic is used as the primary modality of anesthesia, for the following: 1) measure the waste anesthetic gas emanating from patient during the immediate one hour post-operative recovery period in the PACU; 2) measure waste anesthetic gas within PACU caregiver's breathing zone; and 3) determine the efficacy of the ISO-Gard mask in reducing caregiver's exposure to waste anesthetic gas in the PACU. Subjects who will receive either Sevoflurane or Desflurane inhaled anesthetic will be enrolled in this study. Subjects will be randomized to receive either the ISO-Gard scavenging mask or a traditional supplemental oxygen mask post operatively; all other elements of the subjects' care will be in accordance with the institution's standard of care.

Interventions

DEVICEISO-Gard Mask

to scavenge waste anesthetic gases from patients and provide supplemental oxygen

DEVICEStandard oxygen mask

Provide supplemental oxygen

Sponsors

Teleflex
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is 18-120 years of age. * Patients requiring inhaled anesthetic agents as part of their anesthesia during surgery (Sevoflurane or Desflurane) * Patients with following outpatient procedures scheduled for a duration of greater than 2 hours per the operating room schedule: 1. . Bariatric procedures 2. Robotic surgery cases 3. Orthopedic 4. Gynecological procedures 5. ENT 6. Plastic * Not documented as terminally ill * Subject expected to remain in PACU for at least one hour * Subject or legally authorized representative has provided written informed consent prior to the procedure using a form that is approved by the Institutional Review Board (IRB).

Exclusion criteria

* Patients are/were given/planned to be given total IV anesthetics during surgery * Any patient that is not expected to tolerate a mask in PACU * Subject has already been enrolled in study * Subject is an employee of the Investigator or has involvement in other studies under the direction of investigator or study site * Women who are pregnant * End of anesthetic gas administration in PACU bay greater than 45 minutes

Design outcomes

Primary

MeasureTime frameDescription
Waste Anesthetic Gas Measured by Parts Per Million Within PACU Caregiver's Breathing Zone With Caring for Patients1 hour post-operative recovery periodThe measurement of Waste Anesthetic Gas in parts per million resolution emanating from the patient to the caregiver's breathing zone.
Waste Anesthetic Gas Measured by Parts Per Million Emanating From Patients During Normal PACU Working Conditions1 hour post-operative recovery periodThe measurement of Waste Anesthetic Gas in parts per million emanating from the patient between the standard oxygen mask and the ISO-Gard oxygen mask.
Efficacy of the ISO-Gard Mask in Reducing Caregiver's Exposure to WAG-Percentage of Time1 hour post-operative recovery periodFor MAX-WAG measurements obtained every 30 seconds, we calculated the percentage of time in MAX-WAG \[\>2ppm\] relative to the total collection period.
Efficacy of the ISO-Gard Mask in Reducing Caregiver's Exposure to WAG-Duration1 hour post-operative recovery periodFor MAX-WAG measurements obtained every 30 seconds, we calculated the duration of MAX-WAG \[\>2ppm\]

Participant flow

Recruitment details

Patient screening took place in the day surgery unit at Memorial Hermann Hospital in the Texas Medical Center of Houston Texas between July 2015 and November 2015.

Participants by arm

ArmCount
Standard Oxygen Mask
Standard face mask to provide supplemental oxygen Standard oxygen mask: Provide supplemental oxygen
56
ISO-Gard Mask
Face mask to scavenge waste anesthetic gases from patient during recovery from general anesthesia and to provide supplemental oxygen. ISO-Gard Mask: to scavenge waste anesthetic gases from patients and provide supplemental oxygen
52
Total108

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyCase Cancelled20
Overall StudyDevice to measure WAG malfunctioned35
Overall StudyMissed Cases12
Overall StudyNurse Refusal10
Overall StudyProtocol Violation12

Baseline characteristics

CharacteristicStandard Oxygen MaskISO-Gard MaskTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
7 Participants10 Participants17 Participants
Age, Categorical
Between 18 and 65 years
49 Participants42 Participants91 Participants
Sex: Female, Male
Female
41 Participants28 Participants69 Participants
Sex: Female, Male
Male
15 Participants24 Participants39 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 560 / 52
serious
Total, serious adverse events
0 / 560 / 52

Outcome results

Primary

Efficacy of the ISO-Gard Mask in Reducing Caregiver's Exposure to WAG-Duration

For MAX-WAG measurements obtained every 30 seconds, we calculated the duration of MAX-WAG \[\>2ppm\]

Time frame: 1 hour post-operative recovery period

ArmMeasureValue (MEDIAN)
Standard Oxygen MaskEfficacy of the ISO-Gard Mask in Reducing Caregiver's Exposure to WAG-Duration3.0 minutes
ISO-Gard MaskEfficacy of the ISO-Gard Mask in Reducing Caregiver's Exposure to WAG-Duration1.0 minutes
Primary

Efficacy of the ISO-Gard Mask in Reducing Caregiver's Exposure to WAG-Percentage of Time

For MAX-WAG measurements obtained every 30 seconds, we calculated the percentage of time in MAX-WAG \[\>2ppm\] relative to the total collection period.

Time frame: 1 hour post-operative recovery period

ArmMeasureValue (MEDIAN)
Standard Oxygen MaskEfficacy of the ISO-Gard Mask in Reducing Caregiver's Exposure to WAG-Percentage of Time5.2 percentage of time
ISO-Gard MaskEfficacy of the ISO-Gard Mask in Reducing Caregiver's Exposure to WAG-Percentage of Time2.0 percentage of time
Primary

Waste Anesthetic Gas Measured by Parts Per Million Emanating From Patients During Normal PACU Working Conditions

The measurement of Waste Anesthetic Gas in parts per million emanating from the patient between the standard oxygen mask and the ISO-Gard oxygen mask.

Time frame: 1 hour post-operative recovery period

ArmMeasureValue (MEAN)Dispersion
Standard Oxygen MaskWaste Anesthetic Gas Measured by Parts Per Million Emanating From Patients During Normal PACU Working Conditions58.7 parts per millionStandard Deviation 8.1
ISO-Gard MaskWaste Anesthetic Gas Measured by Parts Per Million Emanating From Patients During Normal PACU Working Conditions56.7 parts per millionStandard Deviation 10.2
p-value: 0.26t-test, 2 sided
Primary

Waste Anesthetic Gas Measured by Parts Per Million Within PACU Caregiver's Breathing Zone With Caring for Patients

The measurement of Waste Anesthetic Gas in parts per million resolution emanating from the patient to the caregiver's breathing zone.

Time frame: 1 hour post-operative recovery period

Population: A study size of 100 randomized subjects will be used. Aforementioned sample size was determined to be able to detect an effect size of 0.57 that would provide 80% power and 5% type I error (95% confidence interval and p-0.05 level of significance). Two sample student t-test will be used to do data analysis.

ArmMeasureValue (MEAN)Dispersion
Standard Oxygen MaskWaste Anesthetic Gas Measured by Parts Per Million Within PACU Caregiver's Breathing Zone With Caring for Patients60.6 parts per millionStandard Deviation 20.6
ISO-Gard MaskWaste Anesthetic Gas Measured by Parts Per Million Within PACU Caregiver's Breathing Zone With Caring for Patients56.9 parts per millionStandard Deviation 9.7
p-value: 0.24t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026